Accelerating Cannabinoid Drug Development: Navigating Global Regulatory Challenges for Faster Clinical Progress
- Gain clarity on how evolving international regulations and drug scheduling classifications impact clinical development timelines and trial design for cannabinoid therapeutics
- Discover proactive strategies to align regulatory planning with commercial goals, minimizing delays caused by inconsistent global frameworks
- Learn how to effectively navigate the regulatory distinctions between botanical and synthetic cannabinoids to ensure faster market entry